已核实 DOI PubMed 相关产品: 48

Pigment Epithelium-Derived Factor Deficiency Impairs Hippocampal Glutamate Homeostasis and Cognitive Function by Downregulating Astrocytic GLT-1

Journal 2025 · IF 14.1 · 发表于 2025 年 9 月 14 日
作者: Jin-Hui Shi,Qi-Long Tang,Jin-Hong Wang,Yan-Lan Long,Sai-Feng Zhao,Zhen Zhao,Wan-Ting Xie,Zi-Ming Li,Hao-Ming Lu,Tian-Xiao Gao,Zhen-Zhen Fang,Ti Zhou,Bo-Xing Li,Xia Yang,Guo-Quan Gao,Wei-Wei Qi
阅读全文 在 PubMed 查看

摘要

Maintenance of glutamate homeostasis is essential for synaptic plasticity and cognition. Disrupted glutamate-glutamine cycling causes chronic excitotoxicity, a key driver of cognitive deficits in Alzheimer's disease (AD), though regulatory mechanisms remain unclear. Pigment epithelium-derived factor (PEDF), a neuroprotective protein declining with age, is demonstrated here to play a novel role in synaptic glutamate clearance. Analysis of peripheral blood samples from 19 patients with AD and 75 non-dementia control subjects revealed lower levels of PEDF in patients, and loss of PEDF correlates with cognitive decline. PEDF-deficient mice exhibit defective learning and memory, and higher susceptibility to AD. Furthermore, PEDF deficiency impaired synaptic plasticity and dendritic spine morphology. Mechanistically, PEDF inhibits ubiquitin-proteasome-dependent degradation of astrocytic glutamate transporter-1 (GLT-1) and normally guarantees elimination of synaptic glutamate by modulating the protein kinase C signaling pathway. Strikingly, restoring PEDF rescued cognitive deficits in a mouse model of AD, and upregulation of GLT-1 rescued cognitive impairment in PEDF-deficient mice. Collectively, these findings reveal PEDF is a physiologic regulator of synaptic glutamate homeostasis. Targeting PEDF deficiency-induced neural impairment may provide a novel avenue for the development of new therapeutic applications for neurodegenerative diseases associated with glutamate-induced excitotoxicity.

本研究中使用的阿拉丁产品

48 款产品在本文中被引用